Insmed | INSM

Aktienkurs
126.72
Täglich Wechseln
1.64 1.31%
Monatlich
18.83%
Jährlich
-3.91%
Q3 Prognose
121.08

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 66.70 -0.98 -1.45% 13.86% 2026-08-21
Cytokinetics 77.03 -0.15 -0.19% 100.91% 2026-08-21
DBV Technologies 14.71 0.47 3.30% 54.19% 2026-08-21
Gilead Sciences 146.59 3.15 2.20% 27.73% 2026-08-21
Heron Therapeutics 0.33 0.02 7.06% -76.37% 2026-08-21
Insmed 126.72 1.64 1.31% -3.91% 2026-08-21
Novartis 154.55 2.58 1.70% 24.46% 2026-08-18
Ultragenyx Pharmaceutical 26.60 1.28 5.06% -9.89% 2026-08-21
Regeneron Pharmaceuticals 837.42 10.78 1.30% 42.06% 2026-08-21
Sarepta Therapeutics 19.51 0.29 1.51% -2.74% 2026-08-21

Preis Tag Jahr Datum
USND 26183 116.15 0.45% 21.80% 2026-08-21
US2000 3015 22.77 0.76% 27.66% 2026-08-21